Our ALK-positive experts speak on this panel at the 2019 ALK Positive Summit. From left to right: Board member Colin Barton, Dr. Amy Moore, Dr. Upal Basu Roy, Dr. Vincent Lam, Dr. Christine Lovely WATCH VIDEO
ALK Positive Inc.
Authors: Colin Barton, Dr. Amy Moore, Dr. Upal Basu Roy, Dr. Vincent Lam, Dr. Christine Lovely
Read MoreA discussion of alectinib as a standard for patients with ALK-rearranged non–small cell lung cancer and mechanisms of resistance. WATCH VIDEO
OncLiveTV
Authors: Mark A. Socinski
Review the study design and results of the ALEX trial, comparing alectinib and crizotinib in treatment-naïve ALK-positive patients with non–small cell lung cancer. WATCH VIDEO
OncLiveTV
Authors: Dr. David Spigel
Read MoreA discussion of alectinib as a standard for patients with ALK-rearranged non–small cell lung cancer and mechanisms of resistance. WATCH VIDEO
OncLiveTV
Authors: Mark A. Socinski
Read More
